Our expertise research and development spans the entire life-cycle of a medicine. We have capabilities in both small molecules and biologics. This allows us to search for solutions to unmet medical needs using both modalities, individually or in combination
Pharmaron and AstraZeneca: Working as one team to accelerate drug discovery
In June 2012, AstraZeneca established a partnership to deliver a significant amount of our drug discovery work through collaboration with Pharmaron, a leading R&D service provider based in China. Our shared hope is that this will speed up the discovery of novel medicines that meet unmet patient needs. Pharmaron works closely with our teams to deliver discovery services in chemistry, as well as in drug metabolism and pharmacokinetics (DMPK).
All Directors are collectively responsible for the success of AstraZeneca. Discover general information, images and biographies of our Board of Directors.
AstraZeneca's pipeline is one of the most exciting in the industry. Download the latest version of our development pipeline.
Path to new medicines
The discovery, development and commercialisation of a medicine is a complex process. Information on our path to new medicines and an interactive overview are available.
Visit our dedicated neuroscience site for more information on our research and partnering in the area.
Visit our Open Innovation site to see how we collaborate to push the boundaries of science and deliver life-changing medicines